ICMR to advance 1st in-human trials for Zika, flu, blood cancer therapies

Quick Summary:

First-in-human trial is a type of clinical trial in which a new drug, procedure or treatment is tested in humans for the first time.

The ICMR’s network for Phase 1 clinical trials comprises four strategically located institutions across India.

First-in-human studies take place after the new treatment has been tested in laboratory and animal studies and are usually done as Phase 1 clinical trials.

---

More Pictures

---

Read Quick SummarySave Time

or

Article Details

Category: BusinessFinance

Markets: IndiaMali

Topics: Zika vaccine ICMR New vaccine Cancer vaccine Flue vaccine

Source Website Secure: Yes (HTTPS)

News Sentiment: Negative

Fact Checked: Legitimate

Article Type: News Report

Published On: 2024-09-14 @ 16:06:27 (5 hours ago)

News Timezone: GMT +5:00

News Source URL: business-standard.com

Language: English

Article Length: 473 words

Reading Time: 3 minutes read

Sentences: 16 lines

Sentence Length: 30 words per sentence (average)

Platforms: Desktop Web, Mobile Web, iOS App, Android App

Copyright Owner: © Business Standard

News ID: 22505611

View Article Analysis

About Business Standard

Main Topics: BusinessFinance

Official Website: business-standard.com

Update Frequency: 157 posts per day

Year Established: 1975

Headquarters: India

News Last Updated: 2 hours ago

Coverage Areas: India

Ownership: Independent Company

Publication Timezone: GMT +5:00

Content Availability: Worldwide

News Language: English

RSS Feed: Available (XML)

API Access: Available (JSON, REST)

Website Security: Secure (HTTPS)

Publisher ID: #49

Publisher Details

Frequently Asked Questions